Botulinum toxin A in cerebral palsy: Functional outcomes

被引:26
作者
Graham, HK [1 ]
机构
[1] Univ Melbourne, Parkville, Vic 3052, Australia
[2] Royal Childrens Hosp, Parkville, Vic 3052, Australia
关键词
D O I
10.1067/mpd.2000.109107
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
[No abstract available]
引用
收藏
页码:300 / 303
页数:4
相关论文
共 30 条
[1]  
ALBRIGHT AL, 1995, PEDIATR NEUROSURG, V23, P82
[2]   Intrathecal baclofen in cerebral palsy movement disorders [J].
Albright, AL .
JOURNAL OF CHILD NEUROLOGY, 1996, 11 :S29-S35
[3]   Baclofen in the treatment of cerebral palsy [J].
Albright, AL .
JOURNAL OF CHILD NEUROLOGY, 1996, 11 (02) :77-83
[4]  
[Anonymous], 2000, CLIN DEV MED
[5]   Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial [J].
Barwood, S ;
Baillieu, C ;
Boyd, R ;
Brereton, K ;
Low, J ;
Nattrass, G ;
Graham, HK .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2000, 42 (02) :116-121
[6]  
Boyd R, 1997, EUR J NEUROL, V4, pS15
[7]   Botulinum toxin A in hamstring spasticity [J].
Corry, IS ;
Cosgrove, AP ;
Duffy, CM ;
Taylor, TC ;
Graham, HK .
GAIT & POSTURE, 1999, 10 (03) :206-210
[8]  
Corry IS, 1997, DEV MED CHILD NEUROL, V39, P185
[9]  
COSGROVE AP, 1994, DEV MED CHILD NEUROL, V36, P379
[10]  
COSGROVE AP, 1994, DEV MED CHILD NEUROL, V36, P386